Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if GLSI is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
5 top institutions tracked
Sentiment: bullish
Last trade: buy 77 days ago
Red flags: 1
58 filers reported a long position in GLSI for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| BlackRock, Inc. | $11.4M | 485.9K | +12% |
| VANGUARD CAPITAL MANAGEMENT LLC | $6.5M | 278.2K | -6.7% |
| GEODE CAPITAL MANAGEMENT, LLC | $3.9M | 168.2K | +8.2% |
| STATE STREET CORP | $3.4M | 143.1K | +6.9% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1.9M | 80.9K | +37.3% |
| NORTHERN TRUST CORP | $1.9M | 80.2K | +6.8% |
| Bank of New York Mellon Corp | $1.1M | 47.9K | +3% |
| VANGUARD FIDUCIARY TRUST CO | $1.1M | 46K | +2.4% |
| MORGAN STANLEY | $1M | 43.4K | +45.7% |
| GOLDMAN SACHS GROUP INC | $922.7K | 39.3K | -0.5% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.